Cedax Related Published Studies
Well-designed clinical trials related to Cedax (Ceftibuten)
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections. [2001.09]
[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis] [2001.07.19]
Oral ceftibuten switch therapy for acute pyelonephritis in children. [2001.06]
[Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study)] [2001.06]
[Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study)] [2001.06]
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. [2001]
Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery. [2000.11]
Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children. [2000.09.29]
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children. [1999.12]
[Effectiveness of ceftibuten++ in the sequential therapy of respiratory and urinary tract infections] [1999.07.25]
Treatment of acute sinusitis in childhood with ceftibuten. [1999.05]
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. [1999.03]
Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. [1998.04]
Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine. [1998.03]
Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis. [1998.01]
Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. [1998.01]
Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis. [1997.09]
Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. [1997.07]
Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers. [1997.01]
Comparative bioavailability of ceftibuten in capsule and suspension forms. [1996.11]
Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media. [1996.09]
Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. [1996.05]
Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children. [1996.05]
Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group. [1995.07]
Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group. [1995.07]
Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group. [1995.07]
The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis. [1992.12]
Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. [1992.08]
Ceftibuten versus cefaclor for the treatment of bronchitis. [1991.10]
Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children. [1991.10]
Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections. [1991.01]
Well-designed clinical trials possibly related to Cedax (Ceftibuten)
Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. [2010.04.01]
Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. [2010.04]
Treatment of lower urinary tract infection in pregnancy. [2001.04]
Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. [2000.10]
[Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy] [2000.03]
Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. [1998.12.19]
Epidemiology and treatment of otitis media with effusion in children in the first year of primary school. [1998.07]
Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics. [1988.03]
Other research related to Cedax (Ceftibuten)
Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. [2009.03]
Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. [2008.09.26]
Inhibitory effect of zinc on the absorption of beta-lactam antibiotic ceftibuten via the peptide transporters in rats. [2008]
In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens. [2007.04]
Efficacy of ceftibuten for pediatric patients undergoing adenotonsillectomy. [2000.09]
Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study. [2000.04]
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate. [1999.06]
Clinical evaluation of ceftibuten in gonorrhea. A pilot study in Hong Kong. [1998.10]
[Therapeutic effectiveness of Cedax in the treatment of selected acute upper respiratory diseases] [1998]
Ceftibuten: a new expanded-spectrum oral cephalosporin. [1997.09]
Ceftibuten: an overview. [1997.07]
[The evaluation of ceftibuten (Cedax) effectiveness in the prevention of perioperative infections] [1997]
Ceftibuten concentrations in human tonsillar tissue. [1996.12]
[Effectiveness of and tolerance to ceftibuten in the treatment of chronic bacterial bronchitis exacerbations in an elderly population] [1996.10]
[Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten] [1996.07]
Penetration of ceftibuten into middle ear fluid. [1996.06]
[Morphological response of urinary bacteria to ceftibuten] [1996.03]
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten. [1996.03]
Pharmacokinetics of ceftibuten in children. [1995.07]
Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs. [1995.07]
Worldwide safety experience with ceftibuten pediatric suspension. [1995.07]
Concentrations of ceftibuten in bronchial secretions. [1995.07]
Pharmacokinetics and dose proportionality of ceftibuten in men. [1995.02]
Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers. [1994.09]
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections. [1994.05]
Liquid chromatographic determination of ceftibuten, a new oral cephalosporin, in human plasma and urine. [1994.05]
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. [1994.05]
Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study Group. [1994.04]
Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use. [1994.03]
Impact of ceftibuten on intestinal microflora: in vitro and in vivo studies. [1994]
Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis. [1993.04]
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study. [1993.03]
Determination of a cephalosporin antibiotic, ceftibuten, in human plasma with column-switching high-performance liquid chromatography with ultraviolet detection. [1992.07]
[In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study] [1991.05]
Treatment of acute uncomplicated urinary tract infection with ceftibuten. [1991.03]
The pharmacokinetics of ceftibuten in humans. [1991.01]
Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases. [1991.01]
Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom. [1991.01]
[Clinical studies on ceftibuten in the urinary field infection] [1990.11]
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime. [1990.09]
[Therapeutic efficacy of ceftibuten in chronic respiratory tract infections] [1990.05]
[Clinical examination of ceftibuten in acute bronchitis] [1990.05]
Failure of ceftibuten to alter single dose theophylline clearance. [1990.05]
[Clinical studies of ceftibuten in the field of urology] [1990.02]
[Clinical studies of ceftibuten in the field of obstetrics and gynecology] [1990.01]
Other possibly related research studies
Antibiotic use profile at paediatric clinics in two transitional countries. [2004.03]
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae] [2001.12]
Localized pustulosis induced by betalactams. [2000.05]
[Program of empirical antibacterial therapy of community-acquired pneumonia] [1998]
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. [1998.03]
Empiric antibiotic selection criteria for respiratory infections in pediatric practice. [1997.03]
Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes. [1994.08]
The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. [1994.07]
[Effect of Enterued administration on the intestinal absorption of orally active cefem antibiotics] [1994.04]
[Peroral preparations of cephalosporin antibiotics] [1994.01.03]
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study. [1992.01]
Perioperative use of antibiotics: preventing and treating perioperative infections. [2005.11]
Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. [2004.04]
[Sensitivity of Haemophilus influenzae isolates in Spain to 17 oral antibiotics] [2003.03]
Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. [2002.07]
Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. [2001.09]
Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998. [2000.09]
|